DOCVANOS
ActiveSummary
DOCVANOS has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €563,541 and a net result of €37,281. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 92% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Liquidity more than doubledcurrent ratio 6.90
Current ratio from 2.84 to 6.90; short-term debt falls from €55,378 to €27,297.
26-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 26 days late
2024
31-12
Financial
Equity above €500,000equity €526,260 ▲14.7%
A profit in every financial year since 2018 builds equity to €526,260.
29-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
26-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
28-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Highest result from 2018 to 2025net €76,884 ▲94%
Net result €76,884, the highest in the series.
30-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
16-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 16 days late
2018
25-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
24-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.